Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Exploring the Effect of an Intervention on Women's Physical Activity Behaviour

23 de março de 2020 atualizado por: Jennifer Brunet, University of Ottawa

Exploring the Effect of an eHealth Intervention on Women's Physical Activity Behaviour

Physical activity has been shown to reduce the risk of chronic diseases and promote physical and mental health and wellbeing, yet few women are active enough to see these benefits. Wearable activity trackers show promise for helping people increase their physical activity levels by supporting self-monitoring. However, few researchers have examined how providing people with these devices impacts physical activity levels, or motivation for physical activity which is a significant and robust predictor of physical activity. Based on previous research, it is possible that women's physical activity levels would be more likely to increase if they received an autonomy-supportive intervention to enhance motivation in addition to a wearable activity tracker. A pilot, three-armed randomized controlled trial was developed to test this hypothesis and to assess if changes in perceived autonomy-support, basic psychological need satisfaction/thwarting, motivational regulations, wellbeing indicators are associated with changes in physical activity over time.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Real)

49

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Ontario
      • Ottawa, Ontario, Canadá, K1N6N5
        • University of Ottawa

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 65 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Fêmea

Descrição

All participants will need to meet the following inclusion criteria to participate in the intervention:

  1. Are a woman between the ages of 18 and 65 years
  2. Can understand, read, and speak in English
  3. Are able to safely engage in physical activity
  4. Are not currently pregnant or lactating
  5. Currently participating in less than 150 minutes of moderate or vigorous intensity physical activity and less than two strength training sessions per week
  6. Are overweight or obese (i.e., have a body mass index greater than 25kg/m2)
  7. Have access to the Internet and an email account
  8. Have not used a wearable activity tracker within the past year (e.g., Fitbit, Apple Watch, Garmin, Polar)
  9. Live within 50km of the University of Ottawa

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Group 1
Participants in the main experimental group will receive a copy of the Canadian Physical Activity Guidelines that provide basic information about and recommendations for physical activity, a wearable activity tracker to support self-monitoring, and autonomy-support delivered through weekly emails to help enhance motivation for physical activity.
Participants will receive a copy of the Canadian Physical Activity Guidelines.
Participants will receive a wearable activity tracker (Polar A300).
Participants will receive eight autonomy-supportive weekly emails containing information and activities to help them set goals and make changes to become physically active.
Comparador Ativo: Group 2
Participants in this comparison group will receive a copy of the Canadian Physical Activity Guidelines that provide basic information about and recommendations for physical activity, and a wearable activity tracker to support self-monitoring. They will not receive any specific support to enhance motivation for physical activity.
Participants will receive a copy of the Canadian Physical Activity Guidelines.
Participants will receive a wearable activity tracker (Polar A300).
Comparador Ativo: Group 3
Participants in this information-only comparison group will receive a copy of the Canadian Physical Activity Guidelines that provide basic information about and recommendations for physical activity.
Participants will receive a copy of the Canadian Physical Activity Guidelines.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Physical activity behaviour: International Physical Activity Questionnaire Short Form (IPAQ-S)
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in self-reported physical activity (over the past 7 days) from baseline to post-intervention, and from post-intervention to follow-up.
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Physical activity behaviour: Custom strength and resistance training questionnaire
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in strength and resistance training habits from baseline to post-intervention, and from post-intervention to follow-up.
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Physical activity behaviour: Direct measure
Prazo: Duration of intervention phase (8 weeks).
Change in weekly directly measured levels of physical activity as measured by accelerometers (Polar A300), which will be worn by participants assigned to Group 1 and Group 2 during waking hours for the duration of the intervention.
Duration of intervention phase (8 weeks).
Perceived autonomy support: Perceived Autonomy Support Scale for Exercise Settings (PASSES; Hagger et al., 2007)
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in perceived autonomy support for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Basic psychological need satisfaction: Psychological Need Satisfaction in Exercise Scale (PNSE; Wilson, Rogers, Rodgers, & Wild, 2006)
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in basic psychological need satisfaction for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Motivational regulations: Behavioral Regulation in Exercise Questionnaire (BREQ-2R; Markland & Tobin, 2004; Wilson, Rodgers, Loitz, & Scime, 2006)
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in motivational regulations for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Basic psychological need thwarting: Psychological Need Thwarting Scale (PNTS; Bartholomew, Ntoumanis, Ryan, & Thøgersen-Ntoumani, 2011)
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in basic psychological need thwarting activity from baseline to post-intervention, and from post-intervention to follow-up.
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Positive and Negative Affect Schedule (I-PANAS-SF; Thompson, 2016; Watson, Clark, & Tellegen, 1988).
Prazo: : Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in affect from baseline to post-intervention, and from post-intervention to follow-up.
: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Vitality: Subjective Vitality Scale (Ryan & Frederick, 1997).
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in vitality affect from baseline to post-intervention, and from post-intervention to follow-up.
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Depression: Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001).
Prazo: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in depressive symptoms from baseline to post-intervention, and from post-intervention to follow-up.
Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Wearable activity tracker usage: Multiple choice questions
Prazo: Post-intervention (week 9).
Frequency of wearable activity tracker usage in general during the intervention phase for participants randomized to Group 1 or Group 2.
Post-intervention (week 9).
Recruitment rates
Prazo: Duration of recruitment and intervention phases (9 weeks).
The number of eligible participants who enrol in the study out of the number assessed for eligibility.
Duration of recruitment and intervention phases (9 weeks).
Retention rates
Prazo: Duration of recruitment and intervention phases (9 weeks).
The number of participants completing all scheduled assessments.
Duration of recruitment and intervention phases (9 weeks).
Acceptability: Open ended questions
Prazo: Duration of recruitment and intervention phases (9 weeks).
For participants randomized to Group 1, what participants liked, disliked, and would change about the intervention.
Duration of recruitment and intervention phases (9 weeks).
Body mass
Prazo: Baseline (week 0) and post-intervention (week 9).
Change in body mass measured from baseline to post-intervention as determined using a scale (Tanita BWB 800S).
Baseline (week 0) and post-intervention (week 9).
Body composition
Prazo: Baseline (week 0) and post-intervention (week 9).
Change in body composition from baseline to post-intervention as determined by a scale (Tanita BWB 800S) that uses bioelectrical impedance to assess body composition.
Baseline (week 0) and post-intervention (week 9).
Waist circumference
Prazo: Baseline (week 0) and post-intervention (week 9).
Change in waist circumference from baseline to post-intervention as measured using a measuring tape.
Baseline (week 0) and post-intervention (week 9).

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Sociodemographic questionnaire
Prazo: Baseline (week 0).
Sociodemographic and health information will be collected at baseline to describe the sample. Measures include age, marital status, race, level of education, employment status, household income, number and age of children, self-rated health, medical conditions, menstrual status, smoking history, and weight-related goals.
Baseline (week 0).

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de setembro de 2018

Conclusão Primária (Real)

22 de abril de 2019

Conclusão do estudo (Real)

30 de agosto de 2019

Datas de inscrição no estudo

Enviado pela primeira vez

4 de julho de 2018

Enviado pela primeira vez que atendeu aos critérios de CQ

17 de julho de 2018

Primeira postagem (Real)

26 de julho de 2018

Atualizações de registro de estudo

Última Atualização Postada (Real)

24 de março de 2020

Última atualização enviada que atendeu aos critérios de controle de qualidade

23 de março de 2020

Última verificação

1 de março de 2020

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • eHealth_Women_PA

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

Não

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever